News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|April 15, 2021

Nancy Reau, MD: Increasing HE Awareness and Comfortability for PCPs

Author(s)Nancy Reau, MD

A discussion on the importance of increasing awareness of hepatic encephalopathy for primary care physicians/providers seeing at-risk patients.

Episodes in this series

EP. 1 Arun B. Jesudian, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 1 Arun B. Jesudian, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 2 Arun B. Jesudian, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 2 Arun B. Jesudian, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 3 Arun B. Jesudian, MD: Adapting Care for Outpatients with Recurrent HE

EP. 3 Arun B. Jesudian, MD: Adapting Care for Outpatients with Recurrent HE

EP. 4 Arun B. Jesudian, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 4 Arun B. Jesudian, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 5 Arun B. Jesudian, MD: Increasing Awareness of Hepatic Encephalopathy for PCP

EP. 5 Arun B. Jesudian, MD: Increasing Awareness of Hepatic Encephalopathy for PCP

EP. 6 Arun B. Jesudian, MD: Challenges of ICD10 Coding on Patients with HE

EP. 6 Arun B. Jesudian, MD: Challenges of ICD10 Coding on Patients with HE

EP. 7 Arun B. Jesudian, MD: Advice for Primary Care Physicians

EP. 7 Arun B. Jesudian, MD: Advice for Primary Care Physicians

EP. 8 Nancy Reau, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 8 Nancy Reau, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 9 Nancy Reau, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 9 Nancy Reau, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 10 Nancy Reau, MD: Patient Care Path After HE Hospitalization

EP. 10 Nancy Reau, MD: Patient Care Path After HE Hospitalization

EP. 11 Nancy Reau, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 11 Nancy Reau, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 12 Nancy Reau, MD: Increasing HE Awareness and Comfortability for PCPs

EP. 12 Nancy Reau, MD: Increasing HE Awareness and Comfortability for PCPs

EP. 13 Nancy Reau, MD: Challenges of ICD10 Coding on Patients with HE

EP. 13 Nancy Reau, MD: Challenges of ICD10 Coding on Patients with HE

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Content

Nancy Reau, MD: Challenges of ICD10 Coding on Patients with HE

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD: Patient Care Path After HE Hospitalization

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD: Physical and Economic Impact of Hepatic Encephalopathy

ByNancy Reau, MD

April 15th 2021

Latest CME

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Tina Bhutani, MD, MAS, FAAD; Jason E. Hawkes MD, MS

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

What is ‘butt breathing?’; 1 in 5 UTIs linked to contaminated meat; Walmart becomes first to sell OTC glucose monitor – Morning Medical Update

Survey: Practices turn to AI to ease billing delays and revenue cycle pain

New CMS RADV audits: The good, the bad and the ugly

How to save Medicare Advantage amid swelling enrollment, administrative burdens and financial challenges

Defining AI liability: A conversation with David A. Simon, J.D., LL.M., Ph.D.

© 2025 MJH Life Sciences^®

All rights reserved.